Clinical Evaluation of A New High-speed and High-resolution Intravascular Ultrasound System

Coronary Artery Disease Clinical Trial

— NEW-IVUS  

Official title:

Clinical Evaluation of A New High-speed and High-resolution Intravascular Ultrasound System: A Multi-center Prospective Control Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04739657
• Other study ID #: CTP-02-001
• Status: Completed
• Start date: March 1, 2021
• Est. completion date: April 27, 2021

Study information

• Verified date: May 2022
• Source: Insight Lifetech Co., Ltd.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Insight Lifetech Intravascular Ultrasound Diagnostic System (referred to as Insight Lifetech IVUS system below),is a new high-speed and high-resolution device for clearly defining vessel architecture and plaque morphology, providing quantitative and qualitative assessment of coronary arteries. Besides, IVUS has already an established role in guidance and optimization of percutaneous coronary intervention. This study will compare the differences, if any, between the intravascular ultrasound(IVUS) results measured by the two different IVUS diagnostic systems.

Description:

Many studies have reported that IVUS is an accurate method for determining the size of the target vessel undergoing stent implantation , and the optimal stent deployment (complete stent expansion and apposition and lack of edge dissection or other complications after implantation). The novel 60 megahertz(60MHz) high-definition IVUS has evolved as a next-generation IVUS imaging technology to provide higher image resolution than conventional 40 megahertz(40MHz) IVUS but with sufficient imaging depth preserved for the assessment of the entire vessel wall structure.

Insight Lifetech IVUS system includes TrueVision IVUS diagnostic catheter and VivoHeart IVUS diagnostic console. It is a novel device with high speed, high resolution, and high image acquisition rate enabling high-speed pullback imaging up to 10mm/sec.

This study is a prospective, multi-center, randomized, single-blind, controlled study with the primary target of investigating the differences, if any, between IVUS measurement results by the Insight Lifetech IVUS system and Boston Scientific IVUS system, imaging catheter of which was available at 40MHz during the study. Other purposes included analyzing the feasibility of the Insight Lifetech IVUS system's high-speed pullback during the IVUS assessment. A total of 130 patients will be recruited from 5 centers in China.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: April 27, 2021
• Est. primary completion date: April 27, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age: 18 Years and older;

• Understand and willing to sign the informed consent form;

• Clinical evaluation shows that the coronary artery stent implantation and the intravascular ultrasound(IVUS) guidance is required.

Exclusion Criteria:

• Unable to understand or unwilling to sign the informed consent form;

• Clinically diagnosed with severe coronary artery spasms;

• Contraindicated to percutaneous coronary intervention (PCI);

• Presence of any other factor that the investigator deems is unsuitable for enrollment or completion of this study.

Related Conditions & MeSH terms

• Chronic Total Occlusion of Coronary Artery
• Coronary Artery Disease
• Coronary Disease
• Left Main Coronary Artery Disease
• Myocardial Ischemia
• Percutaneous Coronary Intervention

Intervention

Device:
• Insight Lifetech IVUS System
The Insight Lifetech IVUS System is intended for examination of coronary intravascular pathology only, including TrueVision IVUS diagnostic catheter and VivoHeart IVUS diagnostic device. IVUS imaging is used in patients who will undergo percutaneous coronary intervention.
• Boston Scientific IVUS System
The Boston Scientific IVUS System is intended for the examination of coronary intravascular pathology only, including Opticross IVUS diagnostic catheter and iLAB IVUS diagnostic device. IVUS imaging is used in patients who will undergo percutaneous coronary intervention.

Locations

Country	Name	City	State
China	The General Hospital of the People's Liberation Army	Beijing
China	Guangdong Provincial People's Hospital	Guangzhou
China	Zhongda Hospital of Southeast University	Nanjing
China	Shanghai Zhongshan Hospital	Shanhai
China	The First Affiliated Hospital of Zhengzhou University	Zhengzhou

Sponsors (6)

Lead Sponsor	Collaborator
Insight Lifetech Co., Ltd.	Chinese PLA General Hospital, Guangdong Provincial People's Hospital, Shanghai Zhongshan Hospital, The First Affiliated Hospital of Zhengzhou University, Zhongda Hospital

Country where clinical trial is conducted

China, 

References & Publications (1)

Li C, Yang J, Wang X, et al. CLINICAL VALIDATION OF A NEW INTRAVASCULAR ULTRASOUND SYSTEM: A COMPARATIVE ANALYSIS ON LENGTH MEASUREMENTS. J Am Coll Cardiol. 2022 Mar, 79 (9_Supplement) 827.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mean Stent Area in square millimeter(MSA)	Comparison between the MSA measured by the Insight Lifetech Intravascular Ultrasound Diagnositic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson correlation analysis.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis
Secondary	Clear Stent Length in millimeter (CSL)	Comparison between the CSL measured by the Insight Lifetech Intravascular Ultrasound Diagnostic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson analysis.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis
Secondary	Minimal Lumen Area in square millimeter(MLA)	Comparison between the MLA measured by the Insight Lifetech Intravascular Ultrasound Diagnostic System and Boston Scientific Intravascular Ultrasound Diagnostic System, including mean relative deviation, confidence interval and standard deviation, as assessed by Bland-Altman analysis and Pearson analysis.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis
Secondary	The rate of detected stent malapposition, tissue prolapse and dissection	Detection rate of poor adherence, tissue prolapse and intercalation, for each system individually, and comparison between the two systems.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis
Secondary	Stability of system (questionnaire)	Evaluate the stability of both systems concluded from all enrolled case using questionnaire, including below measures : the stability of IVUS examination ; the usability of system operation; the definition of images.; For each system in 1., 2., and 3., only one of the following five ratings is given: very stable/convenient/clear images; stable/convenient/clear images, inspection was unaffected; slightly unstable/inconvenient/unclear images, inspection was unaffected; unstable/inconvenient/unclear images, inspection was affected; (in the order of 1./2./3.); N/A.; and is counted as 1 point for that particular rating. The distribution of the points in rating and how many points each rating individually owns are compared between the systems.	estimated 1week on average, by opeartor's rating on questionaire
Secondary	Maneuvering performance of catheter (questionnaire)	Evaluate the maneuvering performance of catheters in the two systems concluded from all enrolled case, including below measures : the pushability; the crossability; the angiographic visibility; For each system in 1., 2., and 3., only one of the following five ratings is given: excellent pushability/lesion crossability/visibility; pushing met slight resistance/crossed lesion smoothly/good visibility, inspection was unaffected; pushing met obvious resistance/crossed lesion after attempts/mediocre visibility, inspection was unaffected; too resistant to push/unable to cross lesion/very poor visibility, inspection was affected; (in the order of 1./2./3.); N/A.; and is counted as 1 point for that particular rating. The distribution of the points in rating and how many points each rating individually owns are compared between the systems.	estimated 1week on average, by opeartor's rating on questionaire
Secondary	Device success rate	Device success rate, defined as a valid IVUS image for each system, and comparison between the two systems.	estimated 1day on average, by intraoperative monitoring
Secondary	Rate of device-related adverse effects	Rate of device-related adverse effects, for each system individually, and comparison between the two systems.	estimated 1day on average, by intraoperative monitoring
Secondary	Rate of thrombosis, diffuse lesion and re-stenosis as discerned by IVUS	Rate of thrombosis, diffuse lesion and re-stenosis discerned by each system individually, and comparison between the two systems.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis
Secondary	Rate of plaque rupture and plaque properties as discerned by IVUS	Rates of plaque rupture, lipid-rich plaque, fibrous plaque and calcified plaque, discerned by each system individually, and comparison between the two systems.	estimated 1 month on average, by a third-party corelab IVUS image post-analysis

External Links

•   ACC 2022 online published Abstract